S100A2 and ovarian cancer: As shown in Figure 4A, high expression of GJB2, S100A2, SPOCK2, TGM1or EPS8 indicated a poor OS of patients with ovarian cancer, whereas ovarian cancer patients with higher expression of ADAMDEC1, CHEK1, EGFL6, FAM181A, FOXA2, LYPD1, PART1 or XPR1 possessed better OS.